Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for Aortic structural damage (aneurysm or dilatation)

Annals of the Rheumatic Diseases

Volumn 73, Issue 10, 2014, Pages 1826-1832

  García Martínez, Ana ^a   Arguis, Pedro ^a   Prieto González, Sergio ^a   Espígol Frigolé, Georgina ^a   Alba, Marco A ^a   Butjosa, Montserrat ^a   Tavera Bahillo, Itziar ^a   Hernández Rodríguez, José ^a   Cid, Maria C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881038775     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203322     Document Type: Review

References (23)

1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
2. Salvarani C, Pipitone N, Versari A, et al. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012;8:509-21.
3. García-Martínez A, Prieto-González S, Arguis-Giménez P, et al. Aortitis and aortic aneurysm in systemic vasculitis. In: Grundmann R. ed. Etiology, pathogenesis and pathophysiology of aortic aneurysms and aneurysm rupture. InTech: 137-58.
4. Ostberg G. Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand 1972;533(suppl):135-59.
5. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995;24:422-31.
6. Blockmans D, Ceuninck L, Vanderschueren S, et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;55:131-7.
7. Agard C, Barrier JH, Dupas B, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Artritis Rheum 2008;59:670-6.
8. Prieto-González S, Arguis P, García-Martínez A, et al. Prevalence and characteristics of large-vessel involvement in biopsy-proven giant cell arteritis. Prospective study in 40 newly diagnosed patients using computed tomography angiography. Ann Rheum Dis 2012;71:1170-6.
9. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. Ann Intern Med 1995;122:502-7.
10. Nuenninghoff DM, Hunder GG, Christianson T J H, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis. Arthritis Rheum 2003;48:3522-31.
11. González-Gay MA, García-Porrua C, Piñeiro A, et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain. A population-based study. Medicine 2004;83:335-41.
12. García-Martínez A, Hernández-Rodríguez J, Arguis P, et al. Development of aortic aneurysm/dilatation during the follow-up of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum (AC&R) 2008;59:422-30.
13. Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3532-7.
14. Mackie SL, Hensor E M A, Morgan AW, et al. Should I send my patient with previous giant-cell arteritis for imaging of the thoracic aorta?. A systematic literature review and meta-analysis. Ann Rheum Dis 2014;73:143-8.
15. Aronberg DJ, Glazer HS, Madsen K, et al. Normal thoracic aortic diameters by computed tomography. J Comput Assist Tomogr 1984;8:247-50.
16. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010;121:e266-369.
17. Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant-cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2013;72:1989-94.
18. Espitia O, Néel A, Leux C, et al. Giant-cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with long-term follow-up. J Rheumatol 2012;39:2157-62.
19. Segarra M, García-Martínez A, Sánchez M, et al. Gelatinase expression and proteolytic activity in giant-cell arteritis. Ann Rheum Dis 2007;66:1429-35.
20. El-Hamamsy I, Yacoub MH. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol 2009;6:771-86.
21. Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 2011;473:308-16.
22. Lozano E, Segarra M, García-Martínez A, et al. New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents. Clin Exp Rheumatol 2008;26:S141-150.
23. Direskeneli H, Aydin SZ, Kermani TA, et al. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol 2011;38:1471-9.